Cholangiopancreatography, Endoscopic Retrograde
Conditions
Keywords
Cholangiopancreatography, Endoscopic Retrograde
Brief summary
Although EPBD has a lower risk of post-ERCP bleeding and long-term complications than EST and is easier to perform in altered/difficult anatomy, EPBD is reserved for patients with bleeding diathesis by current consensus because some studies reported a higher risk of pancreatitis. However, recent meta-analyses indicate that short EPBD duration increases the risk of post-ERCP pancreatitis, and EPBD with adequate duration has a similar pancreatitis risk and a lower overall complication rate compared with EST for choledocholithiasis. Therefore, this study aim to compare long-duration EPBD vs EST in the treatment of extrahepatic biliary stones.
Detailed description
Gallstones occur in 10%-15% of adults in the United States and are the most common and costly digestive disorder. Concomitant bile duct stones occur in up to 15% of persons with symptomatic gallstones. Endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy is the standard treatment for removal choledocholithiasis. The biliary sphincter is permanently ablated by sphincterotomy. Enteric-biliary reflux occurs with bacterial colonization, increased bile lithogenicity, contamination with cytotoxins, and chronic inflammation of the biliary system. Endoscopic papillary balloon dilation (EPBD) has become an option for removal of stones 1 cm or smaller in size. Advantages of EPBD over EST include a decreased risk of post-ERCP bleeding as well as a decreased risk of stone recurrence and cholangitis. Although a short dilation duration (≤1 minute) was previously advocated, a study that performed EPBD for 1 minute observed a 15.4% risk of post-ERCP pancreatitis with 2 cases of mortality. European Society of Gastrointestinal Endoscopy guideline recommends that the duration of EPBD should exceed 2 minutes because long-duration EPBD (\>1 minute) is preferred over short-duration EPBD (≤1 minute) with better outcomes. A meta-analysis of RCTs showed that the duration of EPBD is inversely associated with the risk of PEP. Previous RCTs comparing outcome between EPBD and EST used short EPBD duration between 25 seconds and 1 minute, and there has been no comparison of outcome between EST and long-duration EPBD. The aim of this study was to compare the early and long term outcomes of patients treated with long duration balloon dilation or sphincterotomy for extraction of bile duct stones in a randomized, multicenter fashion involving a broad spectrum of practices.
Interventions
PROCEDURElong duration EPBD
An 8-mm dilatation balloon was used for EPBD. Balloons were gradually inflated to maximum pressure for 3 minute, and complete inflation was verified by fluoroscopy.
PROCEDUREEST
After deep cannulation was achieved, a complete sphincterotomy was performed with a 25-mm pull-type sphincterotome (Clever Cut 3; KD-V411M, Olympus, Tokyo, Japan) and the sphincter was divided up to the transverse duodenal fold.
Sponsors
Inje University
The Catholic University of Korea
Wonkwang University
Dankook University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Consecutive patients were invited to participate by the investigators or research staff if they were at least 18 years old, * patients who had known or suspected choledocholithiasis
Exclusion criteria
* active acute pancreatitis * septic shock, * coagulopathy (international normalized ratio \>1.2, partial thromboplastic time greater than twice that of control), * platelet count \<50,000 x 103/uL, * anticoagulation therapy within 48 hours of the procedure, * stone diameter \> 8 mm, * bile duct diameter \>15 mm, prior sphincterotomy, * need for precut sphincterotomy for biliary access, * biliary stricture, * Billroth II or Roux-en-Y anatomy, * periampullary malignancies, * primary sclerosing cholangitis, pregnancy, * and inability to give informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| rate of adverse event | up to 1 month after ERCP | Number of participants with treatment-related adverse events |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| direct cost | within 30 day after ERCP | The direct cost included the total cost for the entire admission, which comprised costs of hospital stay, performed procedures, and management of complications |
| recurrence of choledocholithiasis | more than 3 year follow-up | recurrent choledocholithiasis or acute cholangitis either with or without bile duct stones, and overall hepatobiliary complications |
| the stone clearance rate at the index ERCP | during ERCP | complete extraction of choledocholithiasis of all stones, fragments, and sludge at the initial procedure |
| adverse event (bleeding) | up to 1 month after ERCP | rate of bleeding |
| adverse event (cholangitis) | up to 1 month after ERCP | rate of cholangitis |
| adverse event (pancreatitis) | up to 1 month after ERCP | rate of pancreatitis |
Countries
South Korea
Contacts
Primary ContactJun Ho Choi, MD, PhD
Backup ContactSe Weon Kim, MD
Outcome results
None listed